We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

14 hedge funds and large institutions have $1.7M invested in Viking Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

927% more capital inflows, than outflows

Capital inflows: $516K | Capital outflows: $50.3K

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 13 → 14 (+1)

1.54% more ownership

Funds ownership: 4.46% → 6% (+1.5%)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Sio Capital Management
Sio Capital Management
New York
+$391K
2
Shepherd Kaplan Krochuk
Shepherd Kaplan Krochuk
Massachusetts
+$43.7K
3
Virtu KCG Holdings
Virtu KCG Holdings
New York
+$31.2K
4
Renaissance Technologies
Renaissance Technologies
New York
+$28.2K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$19.5K

Top Sellers

Rank Fund Capital Flow
1
ARTA
A.R.T. Advisors
New York
-$25K
2
Citadel Advisors
Citadel Advisors
Florida
-$21K
3
UBS Group
UBS Group
Switzerland
-$4K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$265

VKTX Hedge Fund Activity: Q3 2016 in Review

14 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2016, worth a combined $1.7M — up 57% from $1.08M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VKTX positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Sio Capital Management, adding an estimated $391K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $25K sold.

  • 14 institutional investors held Viking Therapeutics (VKTX) as of Q3 2016, up from 13 in Q2 2016.
  • Funds reported $1.7M of Viking Therapeutics stock for Q3 2016, up 57% quarter-over-quarter.
  • 4 funds opened new Viking Therapeutics positions in Q3 2016 and 3 closed out, a net change of +1 holder.
  • The largest Viking Therapeutics buyer in Q3 2016 was Sio Capital Management, an estimated $391K added.
  • The largest Viking Therapeutics seller in Q3 2016 was A.R.T. Advisors, an estimated $25K sold.

Based on aggregated 13F filings for Q3 2016.